Connection

Yazdan Yazdanpanah to Cohort Studies

This is a "connection" page, showing publications Yazdan Yazdanpanah has written about Cohort Studies.
Connection Strength

0.139
  1. Impact on disease mortality of clinical, biological, and virological characteristics at hospital admission and overtime in COVID-19 patients. J Med Virol. 2021 04; 93(4):2149-2159.
    View in: PubMed
    Score: 0.040
  2. [Antiretroviral drugs in severe acute respiratory syndrome]. Presse Med. 2006 Jan; 35(1 Pt 2):105-7.
    View in: PubMed
    Score: 0.014
  3. Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity. Nat Immunol. 2021 03; 22(3):322-335.
    View in: PubMed
    Score: 0.010
  4. A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations. Sci Transl Med. 2020 09 02; 12(559).
    View in: PubMed
    Score: 0.010
  5. Voluntary Community Human Immunodeficiency Virus Testing, Linkage, and Retention in Care Interventions in Kenya: Modeling the Clinical Impact and Cost-effectiveness. Clin Infect Dis. 2018 08 16; 67(5):719-726.
    View in: PubMed
    Score: 0.009
  6. High virological suppression regardless of the genotypic susceptibility score after switching to a dolutegravir-based regimen: week 48 results in an observational cohort. J Antimicrob Chemother. 2018 06 01; 73(6):1665-1671.
    View in: PubMed
    Score: 0.008
  7. The acceptability and effectiveness of a questionnaire for the identification of risk factors for HIV and hepatitis B and C: An observational study in general practice. Eur J Gen Pract. 2018 Dec; 24(1):60-67.
    View in: PubMed
    Score: 0.008
  8. The negative impact of HBV/HCV coinfection on cirrhosis and its consequences. Aliment Pharmacol Ther. 2017 12; 46(11-12):1054-1060.
    View in: PubMed
    Score: 0.008
  9. Prevalence of gag mutations associated with in vitro resistance to capsid inhibitor GS-CA1 in HIV-1 antiretroviral-naive patients. J Antimicrob Chemother. 2017 10 01; 72(10):2954-2955.
    View in: PubMed
    Score: 0.008
  10. Switch as maintenance to elvitegravir/cobicistat/emtricitabine/tenofovir disoproxil fumarate: week 48 results in a clinical cohort. J Antimicrob Chemother. 2017 06 01; 72(6):1745-1751.
    View in: PubMed
    Score: 0.008
  11. Budget impact of antiretroviral therapy in a French clinic cohort. AIDS. 2017 06 01; 31(9):1271-1279.
    View in: PubMed
    Score: 0.008
  12. Characteristics and consequences of medical care interruptions in HIV-infected patients in France. Epidemiol Infect. 2016 08; 144(11):2363-70.
    View in: PubMed
    Score: 0.007
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.